Yu Kang

机构：Tianjin University, Hefei University of Technology, Guizhou University, Chinese Academy of Sciences, Nankai University, Beijing Institute of Genomics, Shanghai Innovative Research Center of Traditional Chinese Medicine, Maria Fertility Hospital, Guizhou Minzu University, Zhejiang Lab, Tasly Holding Group (China), Institute of Rock and Soil Mechanics, Zhejiang Pharmaceutical College, Taiyuan University of Science and Technology, Ulsan National Institute of Science and Technology, Tianjin Medical University, Beijing University of Chemical Technology, Zhejiang University, Taiyuan University of Technology · ORCID：0000-0002-0999-8802

发表论文 562 篇 · 总被引 13889 次 · h-index 66

代表论文

• A complete diploid human genome benchmark for personalized genomics (2026 · Cell · 被引 27)
• Unlocking the application potential of AlphaFold3-like approaches in virtual screening (2025 · Chemical Science · 被引 13)
• Facilitating structure-based drug discovery with an artificial intelligence-driven virtual screening platform (2026 · Nature Protocols · 被引 1)
• Structure Tailoring Enabled Self‐Catalyzed Imidization for Engineering a Highly Adhesive and Ion‐Conductive Polyimide Network Toward Ultra‐Stable Silicon Anodes (2026 · Angewandte Chemie · 被引 1)
• In situ strategy to overcome the trade-off between deep penetration and high-density crosslinking in adhesives for painted architectural relics conservation (2026 · Construction and Building Materials · 被引 1)
• AutoLoop is an autoregressive deep learning method for protein loop prediction with high accuracy (2026 · Cell Reports Physical Science · 被引 1)